More specifically, this drug binds the E3 ligase substrate adaptor CRBN (cereblon) to degrade IKZF1 (zinc finger region of protein) and the casein kinase 1α (CK1α), thereby leading to cell cycle arrest and apoptosis in MM. Here, CRBN is linked to Miyoshi myopathy.